Daniel M. Junius is Director at IDEXX LABORATORIES INC /DE (IDXX). They have made 29 open-market trades across 3 companies since 2007, most recently 2026-05-07.
CIK 0001094159
10 open-market purchases totalling $509K since 2007, against 19 sales. Across 10 scored buys the stock is up 4.3% at ninety days, and 0.4 points ahead of the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 30% | 10% | 20% |
| Avg Move | -15.6% | +0.3% | +4.3% |
| Alpha | -11.2% | -0.4% | +0.4% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IDXX | SELL | 2025-05-13 | 2025-05-14 | $506.41 | $2.7M | +1.7% | +2.9% | +28.4% |
| GLYC | BUY | 2023-05-10 | 2023-05-11 | $1.56 | $47K | +3.8% | +0.0% | -13.6% |
| IDXX | SELL | 2023-02-16 | 2023-02-17 | $511.68 | $2.2M | -2.2% | -0.7% | +1.1% |
| IDXX | SELL | 2022-12-05 | 2022-12-07 | $424.91 | $2.6M | -4.2% | +6.7% | +12.9% |
| GLYC | BUY | 2022-11-17 | 2022-11-18 | $1.87 | $37K | -8.5% | -6.0% | -22.4% |
| IDXX | SELL | 2021-08-10 | 2021-08-12 | $679.58 | $3.3M | +0.2% | -2.4% | -7.3% |
| IDXX | SELL | 2021-05-21 | 2021-05-24 | $539.57 | $2.7M | +1.6% | +12.1% | +22.1% |
| IDXX | SELL | 2021-02-22 | 2021-02-24 | $538.57 | $2.0M | -9.0% | -9.4% | +4.7% |
| IDXX | SELL | 2020-08-20 | 2020-08-21 | $382.61 | $2.8M | +5.7% | -5.1% | +19.0% |
| IDXX | SELL · Routine | 2020-05-19 | 2020-05-20 | $295.61 | $1.2M | +8.3% | +7.7% | +32.3% |
| GLYC | BUY | 2020-03-09 | 2020-03-10 | $3.40 | $68K | -32.9% | -14.2% | +3.2% |
| GLYC | BUY | 2019-08-13 | 2019-08-15 | $3.18 | $32K | +5.0% | +46.9% | +96.9% |
| IMGN | SELL | 2018-03-16 | 2018-03-16 | $12.02 | $301K | -12.4% | -15.8% | -14.4% |
| IDXX | SELL | 2018-02-28 | 2018-03-02 | $190.06 | $1.1M | +10.4% | +1.2% | +12.9% |
| IMGN | SELL | 2018-02-21 | 2018-02-23 | $12.00 | $141K | +3.9% | +15.5% | -5.6% |
| IMGN | SELL | 2018-02-20 | 2018-02-21 | $11.68 | $292K | -2.5% | +2.7% | -12.5% |
| IMGN | SELL | 2018-02-13 | 2018-02-14 | $10.01 | $934K | +6.3% | +19.0% | +0.6% |
| IDXX | SELL | 2017-02-08 | 2017-02-09 | $141.75 | $425K | +0.1% | +6.7% | +14.7% |
| GLYC | BUY | 2016-12-20 | 2016-12-21 | $6.01 | $30K | +1.8% | -7.9% | -5.3% |
| IMGN | SELL | 2016-01-04 | 2016-01-04 | $13.17 | $71K | -24.1% | -40.8% | -27.9% |
| IMGN | SELL | 2016-01-04 | 2016-01-04 | $13.17 | $143K | -24.1% | -40.8% | -27.9% |
| IMGN | SELL · 10b5-1 | 2015-12-01 | 2015-12-01 | $13.11 | $71K | -29.5% | -3.5% | -45.1% |
| IMGN | SELL · 10b5-1 | 2015-11-02 | 2015-11-03 | $12.00 | $66K | -29.5% | -3.5% | -39.1% |
| IMGN | SELL · 10b5-1 | 2015-10-29 | 2015-10-30 | $12.01 | $64K | -29.5% | -3.5% | -35.3% |
| IMGN | SELL · 10b5-1 | 2015-09-01 | 2015-09-01 | $13.15 | $71K | -29.5% | -3.5% | -3.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.